RE: Pfeizer11 Nov 2020 21:52
early december at the earliest for interim data from oxford...but like pfizer, they are struggling for covid cases to make their data meaningful...more like early 2021 from both and with no other phase 3 trials where UK have a stake currently running, companies like orphy, rms and sng still in pole position.